Targeting the Id1-Kif11 Axis in Triple-Negative Breast Cancer Using Combination Therapy

The basic helix-loop-helix (bHLH) transcription factors inhibitor of differentiation 1 (<i>Id1</i>) and inhibitor of differentiation 3 <i>(Id3)</i> (referred to as <i>Id</i>) have an important role in maintaining the cancer stem cell (CSC) phenotype in the triple-...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Archana P. Thankamony, Reshma Murali, Nitheesh Karthikeyan, Binitha Anu Varghese, Wee S. Teo, Andrea McFarland, Daniel L. Roden, Holly Holliday, Christina Valbirk Konrad, Aurelie Cazet, Eoin Dodson, Jessica Yang, Laura A. Baker, Jason T. George, Herbert Levine, Mohit Kumar Jolly, Alexander Swarbrick, Radhika Nair
Formato: Artigo
Idioma:Inglês
Publicado: MDPI AG 2020-09-01
Series:Biomolecules
Assuntos:
cancer stem cells
chemoresistance
self-renewal
combination therapy
<i>Id1</i>
<i>Kif11</i>
Acceso en liña:https://www.mdpi.com/2218-273X/10/9/1295
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares